Barclays maintains Overweight on Newmont, lowers target to $125
Barclays analyst Richard Garchitorena maintains an Overweight rating on Newmont (NYSE: NEM) while reducing the price target from $133 to $125.

*this image is generated using AI for illustrative purposes only.
Barclays analyst Richard Garchitorena has adjusted the price target for Newmont while maintaining an Overweight rating on the stock. The firm lowered its price objective to $125, down from the previous $133, reflecting updated valuation metrics.
Newmont trades on the NYSE under the ticker symbol NEM.
Rating and Target Details
The following table outlines the revised analyst metrics:
| Metric | Value |
|---|---|
| Rating | Overweight |
| Previous Price Target | $133 |
| New Price Target | $125 |
What specific valuation metrics prompted Barclays to lower Newmont's price target?
How might the current gold price environment influence Newmont's ability to meet the revised target?
Are there operational challenges or cost pressures affecting Newmont's profitability?




























